http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104230808-B

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D223-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D223-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55
filingDate 2014-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2016-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2016-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-104230808-B
titleOfInvention Amorphous ivabradine hydrochloride and preparation method thereof and application
abstract The invention belongs to pharmaceutical chemistry field, be specifically related to a kind of amorphous ivabradine hydrochloride and preparation method thereof and application. The preparation method of amorphous ivabradine hydrochloride of the present invention, comprise the step of preparing the hydrochloric acid Ivabradine aqueous solution by soluble in water hydrochloric acid Ivabradine, after filtration, get filtrate and under vacuum condition, carry out freeze drying processing, obtain required amorphous ivabradine hydrochloride. This preparation method is reproducible, process stabilizing, be suitable for suitability for industrialized production, and the crystal formation of preparation is to be easy to control as single amorphous ivabradine hydrochloride.
priorityDate 2014-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21885828
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449401048
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448478793
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3045381

Total number of triples: 22.